» Authors » Lena Pracher

Lena Pracher

Explore the profile of Lena Pracher including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 2
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jorda A, Pracher L, Eberl S, Nussbaumer-Proll A, Sarhan M, Weber M, et al.
Med Microbiol Immunol . 2025 Mar; 214(1):14. PMID: 40047923
Whether the magnitude of individual cytokine, cellular, and clinical responses to the intravenous lipopolysaccharide (LPS) challenge is constant in individuals over extended time periods is unknown. Nine healthy volunteers received...
2.
Bergmann F, Prager M, Pracher L, Sawodny R, Steiner-Gager G, Richter B, et al.
J Intern Med . 2025 Mar; PMID: 40041991
Background: The optimal systolic blood pressure (SBP) target in patients with increased cardiovascular risk remains uncertain. This study evaluated the efficacy and safety of intensive SBP control (<120 mm Hg)...
3.
Jorda A, Prager M, Pracher L, Haselwanter P, Jackwerth M, Al Jalali V, et al.
J Infect . 2025 Jan; 90(2):106405. PMID: 39756693
Objectives: There is conflicting evidence as to whether the combined administration of two vaccines can lead to poorer immunogenicity and reactogenicity. The co-administration of the Omicron-adapted COVID-19 vaccine from Novavax...
4.
Pracher L, Zeitlinger M
Clin Microbiol Infect . 2024 Oct; PMID: 39389465
Background: Viral diseases represent a substantial global health challenge, necessitating the urgent development of effective antiviral medications. Objectives: This review aims to present a thorough examination of systemic antiviral drugs...
5.
Mairinger S, Jackwerth M, Chalampalakis Z, Rausch I, Weber M, Wolfl-Duchek M, et al.
Eur J Nucl Med Mol Imaging . 2024 Jul; 51(13):3900-3911. PMID: 39060376
Purpose: Multidrug resistance-associated protein 1 (MRP1) is a transport protein with a widespread tissue distribution, which has been implicated in the pathophysiology of Alzheimer's and chronic respiratory disease. PET with...
6.
Jorda A, Eberl S, Nussbaumer-Proll A, Sarhan M, Weber M, Tegrovsky L, et al.
J Inflamm Res . 2024 Jul; 17:4781-4790. PMID: 39051050
Introduction: Lipopolysaccharide (LPS) stimulation of human whole blood ex vivo has been widely used to investigate human innate immune responses. However, there are uncertainties regarding the reproducibility and reliability of...
7.
Zadrazil M, Marhofer P, Opfermann P, Schmid W, Marhofer D, Zeilberger M, et al.
Anesthesiology . 2024 Apr; 141(1):24-31. PMID: 38558118
Background: Little is known about the pharmacodynamic characteristics of liposomal bupivacaine. Hypothesizing that they would not identify pharmacodynamic differences from plain bupivacaine during the initial period after administration, but would...
8.
Bergmann F, Pracher L, Sawodny R, Blaschke A, Gelbenegger G, Radtke C, et al.
Clin Infect Dis . 2023 Oct; 77(12):1704-1713. PMID: 37876267
Background: Community-acquired pneumonia (CAP) is associated with high morbidity and mortality. In the present study, we aimed to assess the effect of corticosteroids on all-cause mortality in patients hospitalized with...
9.
Bibl K, Pracher L, Kung E, Wagner M, Roesner I, Berger A, et al.
Front Pediatr . 2022 May; 10:864766. PMID: 35633947
Background: Endotracheal intubation is a common procedure in Neonatal Intensive Care. While cuffed endotracheal tubes (ETT) are the standard of care in adults and children, their use in infants is...